0001615774-17-001101.txt : 20170316
0001615774-17-001101.hdr.sgml : 20170316
20170316173640
ACCESSION NUMBER: 0001615774-17-001101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170314
FILED AS OF DATE: 20170316
DATE AS OF CHANGE: 20170316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC
CENTRAL INDEX KEY: 0001266806
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
BUSINESS PHONE: 818-833-5000
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGuire Jonathan Will
CENTRAL INDEX KEY: 0001345539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36747
FILM NUMBER: 17695662
MAIL ADDRESS:
STREET 1: 96 TALAMINE COURT
CITY: COLORADO SPRINGS
STATE: CO
ZIP: 80907
4
1
s105584_form4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-03-14
0
0001266806
SECOND SIGHT MEDICAL PRODUCTS INC
EYES
0001345539
McGuire Jonathan Will
12744 SAN FERNANDO ROAD
SUITE 400
SYLMAR
CA
91342
0
1
0
0
Chief Executive Officer
Common Stock
2017-03-14
2017-03-14
4
A
0
6794
1.47
A
59798
D
Warrant to Purchase Common Stock
1.47
2017-03-14
4
A
0
6794
A
2017-03-14
2022-03-14
Common Stock
6794
6794
D
Non-Qualified Stock Option (right to buy)
1.97
2018-01-03
2027-01-03
Common Stock
571330
571330
D
Non-Qualified Stock Option (right to buy)
4.1
2017-01-21
2026-01-21
Common Stock
21290
21290
D
Non-Qualified Stock Option (right to buy)
12.43
2016-08-17
2025-08-17
Common Stock
420000
420000
D
Restricted Stock Unit (RSU)
2016-08-17
2019-08-17
Common Stock
190000
118750
D
Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017.
Options and RSUs vest over a 4 year term, with 25% vesting on the date exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%.
Each restricted stock unit represents a contingent right to receive one share of common stock of the Company.
/s/ Jonathan Will McGuire
2017-03-16